Approximately one-fourth of all strokes are caused by carotid artery disease, a condition wherein one or both carotid arteries in the neck become blocked by plaque, which can break off and cause stroke. Traditional surgical treatment for carotid artery disease often involves general anesthesia and requires an incision in a patient's neck to remove plaque from inside the artery wall. Carotid artery stenting is a minimally invasive treatment option for patients who require intervention to prevent a stroke and are at high risk for complications from traditional surgery. The procedure is performed by delivering a stent on a catheter through the femoral artery in the groin. The catheter is maneuvered through the patient's vasculature to the carotid artery. The stent, which is designed to prevent arterial plaque and debris from breaking off and blocking blood flow to the brain, is then expanded at the site of the blockage.
The Society for Vascular Surgery published its first supplement on diversity articles to its Journal of Vascular Surgery in April 2010.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
An important interventional radiology advancement-the use of a new cerebral protection device in combination with FDA-approved carotid stents in high-surgical-risk patients-provides a minimally invasive, safe and effective way to prevent stroke from occurring during treatment to clear blocked carotid arteries, according to research released at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved its Express® LD Iliac Premounted Stent System for use in iliac arteries. The Express LD Iliac Stent is the first and only low-profile, premounted, balloon-expandable stent approved by the FDA for use in treating iliac artery disease. The Company said it plans to launch the product immediately in the United States.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, recent preliminary results from the CREST (Carotid Revascularization Endarterectomy versus Stenting Trial) will support growth in carotid stenting procedures of more than 10% over the next five years. The results were announced last week at the American Stroke Association International Stroke Conference 2010.
A multicenter EPIC (FiberNet- Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System (EPS) had a 97.5% success rate when used in patients undergoing carotid artery stenting (CAS). Full findings are published early online in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.
The two major procedures for opening blocked neck arteries to restore blood flow to the brain proved similar in overall long-term safety and efficacy, but showed differences in stroke and heart attack in the weeks following the procedure, according to late-breaking science presented at the American Stroke Association's International Stroke Conference 2010.
Carotid artery stenting, a less invasive alternative to surgery on the carotid artery (carotid endarterectomy), is equally safe and effective for people at risk for stroke as carotid endarterectomy, according to a major new study presented today at the 2010 International Stroke Conference in San Antonio, Texas.
HealthYes!®, a leading mobile medical screening provider, is offering several new preventive screenings directly focused on heart disease. The new tests include: a six-lead electrocardiogram (EKG), cholesterol finger-stick, and 10-year Framingham Cardiac Risk Score as well as diabetes and liver function testing.
The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows.
The Society of Interventional Radiology offers numerous resources-including publications and the first-ever Catheter Lysis of Thromboembolic Stroke (CLOTS) course-for interventional radiologists, neuroradiologists, neurointerventionists, body interventionalists, and IR and INR fellows to aid in the understanding of stroke and carotid artery disease.
Invatec, a comprehensive innovator of interventional products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Mo.Ma® Ultra Proximal Cerebral Protection Device for use during carotid artery stenting (CAS).
Reverse Medical Corporation announced today they have initiated human use of their ReStore™ Microcatheter for reestablishing blood flow in the Neurovasculature. The device was successfully used in an acute ischemic stroke patient in Germany.
Reverse Medical Corporation announced today that it has received US Food and Drug Administration (FDA) conditional approval to begin a neurothrombectomy IDE study for its ReStore™ Microcatheter at twenty US centers. The study is planned to begin enrollment in US and European hospitals following investigating study center Institutional Review Board (IRB) approvals.
Virginia Interventional and Vascular Associates (VIVA) and its parent group, Radiologic Associates of Fredericksburg (RAF) Ltd., announce that Victor J. D'Addio, M.D., FACS, has joined the practice. Dr. D'Addio is a board-certified vascular surgeon. Together, the practice offers streamlined services for vascular patients and referring physicians -- from office-based vascular testing to minimally invasive treatments and traditional surgery.
Carotid endarterectomy (CEA) yields better short-term results than carotid artery stenting (CAS) in patients with carotid artery disease, according to a 30-day outcomes report from the Society for Vascular Surgery (SVS) Vascular Registry for Carotid Procedures, published in the January 2009 issue of the Journal of Vascular Surgery, by the Society for Vascular Surgery.
Boston Scientific Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved its Carotid WALLSTENT Monorail Endoprosthesis for the treatment of patients with carotid artery disease who are at high risk for surgery.
Repeat exams using widely available and inexpensive ultrasound imaging could help identify patients at high risk for a heart attack or other adverse cardiovascular events, according to a study published in the September issue of the journal Radiology.
How the body regulates blood pressure in response to daily stress is the focus of a study geared toward helping people whose pressure is out of control.
Carotid artery stenting is an effective option for high risk patients who are not eligible for surgery, according to a long-term study published in this week's New England Journal of Medicine.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.